MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Idecabtagene vicleucel

  1. Home
  2. Drugs
  3. Idecabtagene vicleucel
  4. Clinical Trials

Clinical Trials Related to Idecabtagene vicleucel

Related studies linked through entity extraction aliases.

NCT06855121

The Norwegian Immunotherapy in Multiple Myeloma Study

Status
RECRUITING
Phase
N/A

NCT06698887

A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

Status
RECRUITING
Phase
N/A

NCT06357754

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Status
RECRUITING
Phase
N/A

NCT06154902

Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel

Status
ACTIVE_NOT_RECRUITING
Phase
N/A

NCT06045806

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE3

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.